Maribavir versus investigator assigned therapy : Exploring the exploratory
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Transplant infectious disease : an official journal of the Transplantation Society - 25(2023), 3 vom: 28. Juni, Seite e14063 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Heldman, Madeleine R [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antiviral Agents |
---|
Anmerkungen: |
Date Completed 19.06.2023 Date Revised 06.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/tid.14063 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM355574438 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM355574438 | ||
003 | DE-627 | ||
005 | 20240306232246.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/tid.14063 |2 doi | |
028 | 5 | 2 | |a pubmed24n1318.xml |
035 | |a (DE-627)NLM355574438 | ||
035 | |a (NLM)37053091 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Heldman, Madeleine R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Maribavir versus investigator assigned therapy |b Exploring the exploratory |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.06.2023 | ||
500 | |a Date Revised 06.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Editorial | |
650 | 4 | |a cytomegalovirus | |
650 | 4 | |a healthcare resource utilization | |
650 | 4 | |a maribavir | |
650 | 7 | |a maribavir |2 NLM | |
650 | 7 | |a PTB4X93HE1 |2 NLM | |
650 | 7 | |a Antiviral Agents |2 NLM | |
700 | 1 | |a Limaye, Ajit P |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Transplant infectious disease : an official journal of the Transplantation Society |d 1999 |g 25(2023), 3 vom: 28. Juni, Seite e14063 |w (DE-627)NLM113005482 |x 1399-3062 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2023 |g number:3 |g day:28 |g month:06 |g pages:e14063 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/tid.14063 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2023 |e 3 |b 28 |c 06 |h e14063 |